SCHEMBL31751652

SCHEMBL31751652

CC(C)(C)OC(=O)NCc1cc2c(Cl)nccc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ ATR Q13535 1/20 0.44
▸ MTNR1A P48039 3/20 0.41
▸ MTNR1B P49286 3/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CACNA1H O95180 1/20 0.40
▸ CACNA1B Q00975 1/20 0.40
▸ CACNA1C Q13936 1/20 0.40
▸ KDM4A O75164 1/20 0.39
▸ BCHE P06276 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ PARP1 P09874 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ NAMPT P43490 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ GRM2 Q14416 1/20 0.36
▸ PRMT5 O14744 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23478663 0.77 SMN1; SMN2 (0.48) SMN1; SMN2CACNA1HCACNA1BCACNA1CKDM4A
SCHEMBL30632885 0.77 SMN1; SMN2 (0.48) SMN1; SMN2CACNA1HCACNA1BCACNA1CKDM4A
SCHEMBL30759248 0.77 BCHE (0.49) SMN1; SMN2MTNR1AMTNR1BL3MBTL1CACNA1H
SCHEMBL23436429 0.77 SMN1; SMN2 (0.51) SMN1; SMN2L3MBTL1CACNA1HCACNA1BCACNA1C
SCHEMBL19249105 0.76 CTSV (0.46) SMN1; SMN2MTNR1AMTNR1BL3MBTL1CACNA1H
SCHEMBL30967628 0.76 CKS1B (0.37) ATRBCHEPARP1KDM4EPOLB
SCHEMBL19964841 0.75 SMN1; SMN2 (0.45) SMN1; SMN2CACNA1HCACNA1BCACNA1CKDM4A
SCHEMBL16808752 0.74 MTNR1A (0.47) SMN1; SMN2MTNR1AMTNR1BCACNA1HCACNA1B
SCHEMBL30469092 0.74 KDM4A (0.54) SMN1; SMN2MTNR1AMTNR1BCACNA1HCACNA1B
SCHEMBL25677972 0.74 KDM4A (0.54) SMN1; SMN2MTNR1AMTNR1BCACNA1HCACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025264954-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2025-12-26 — — WO disclosed
Send feedback